Noninvasive Diagnosis of Cellular and Antibody-Mediated Rejection by Perforin and Granzyme B in Renal Allografts

Human Immunology

Volumn 67, Issue 10, 2006, Pages 777-786

  Veale, Jeffrey L ^a   Liang, Leonard W ^a   Zhang, Qiuheng ^a   Gjertson, David W ^a   Du, Zeying ^a   Bloomquist, Erik W ^a   Jia, Juan ^a   Qian, Lei ^a   Wilkinson, Alan H ^a   Danovitch, Gabriel M ^a   Pham, Phuong Thu T ^a   Rosenthal, J Thomas ^a   Lassman, Charles R ^a   Braun, Jonathan ^a   Reed, Elaine F ^a   Gritsch, H Albin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibody mediated rejection; Cellular rejection; Granzyme B; Novel statistical analysis; Perforin

Indexed keywords

ANTIBODY; BASILIXIMAB; CYCLOSPORIN; GRANZYME B; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PERFORIN; PREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MARKER GENE; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECIPIENT; TISSUE LEVEL;

ADULT; ANTIBODY FORMATION; BIOPSY; FEMALE; GENE EXPRESSION; GRAFT REJECTION; GRANZYMES; HUMANS; IMMUNITY, CELLULAR; KAPLAN-MEIER ESTIMATE; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PERFORIN; PORE FORMING CYTOTOXIC PROTEINS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 33750014237     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.07.006     Document Type: Article

References (37)

1. Murray J.E., Merrill J.P., and Harrison J.H. Renal homotransplantation in identical twins. Surg Forum 6 (1955) 432
2. Hariharan S., Johnson C.P., Bresnahan B.A., Taranto S.E., McIntosh M.J., and Stablein D. Improved graft survival after renal transplantation in the United States, 1988-1996. N Engl J Med 342 (2000) 605
3. Rush D. Protocol biopsies should be part of the routine management of kidney transplant recipients. Am J Kidney Dis 40 (2002) 674
4. Lachenbruch P.A., Rosenberg A.S., Bonvini E., Cavaille-Coll M.W., and Colvin R.B. Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design. Am J Transplant 4 (2004) 451
5. Barry M., and Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2 (2002) 401
6. Trapani J.A., and Smyth M.J. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2 (2002) 735
7. Sharma V.K., Bologa R.M., Li B., Xu G.P., Lagman M., Hiscock W., Mouradian J., Wang J., Serur D., Rao V.K., and Suthanthiran M. Molecular executors of cell death-differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation 62 (1996) 1860
8. Li B., Hartono C., Ding R., Sharma V.K., Ramaswamy R., Qian B., Serur D., Mouradian J., Schwartz J.E., and Suthanthiran M. Noninvasive diagnosis of renal allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 344 (2001) 947
9. Simon T., Opelz G., Wiesel M., Ott R.C., and Susal C. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 3 (2003) 1121
10. Netto M.V., Fonseca B.A., Dantas M., Saber L.T., Castro M.C., and Ferraz A.S. Granzyme B, FAS-ligand and perforin expression during acute cellular rejection episodes after kidney transplantation: comparison between blood and renal aspirates. Transplant Proc 34 (2002) 476
11. Desvaux D., Schwarzinger M., Pastural M., Baron C., Abtahi M., Berrehar F., Lim A., Lang P., and le Gouvello S. Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance. Transplantation 78 (2004) 647
12. Beik A.I., Morris A.G., Higgins R.M., and Lam F.T. Serial flow cytometric analysis of T-cell surface markers can be useful in differential diagnosis of renal allograft dysfunction. Clin Transplant 12 (1998) 24
13. Zhang Q., Liang L.W., Gjertson D.W., Lassman C., Wilkinson A.H., Kendrick E., Pham P.T., Danovitch G.M., Gritsch H.A., and Reed E.F. Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction. Transplantation 79 (2005) 591
14. Mauiyyedi S., and Colvin R.B. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 11 (2002) 609
15. Collins A.B., Schneeberger E.E., Pascual M.A., Saidman S.L., Williams W.W., Tolkoff-Rubin N., Cosimi A.B., and Colvin R.B. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 10 (1999) 2208
16. Feucht H.E., Felber E., Gokel M.J., Hillebrand G., Nattermann U., Brockmeyer C., Held E., Riethmuller G., Land W., and Albert E. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 86 (1991) 464
17. Feucht H.E., Schneeberger H., Hillebrand G., Burkhardt K., Weiss M., Riethmuller G., Land W., and Albert E. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 43 (1993) 1333
18. Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., Croker B.P., Demetris A.J., Drachenberg C.B., Fogo A.B., Furness P., Gaber L.W., Gibson I.W., Glotz D., Goldberg J.C., Grande J., Halloran P.F., Hansen H.E., Hartley B., Hayry P.J., Hill C.M., Hoffman E.O., Hunsicker L.G., Lindblad A.S., and Yamaguchi Y. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 713
19. Sabek O., Dorak M.T., Kotb M., Gaber A.O., and Gaber L. Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation 74 (2002) 701
20. Abruzzo L.V., Lee K., Fuller A., Silverman A., Keating M.J., Medeiros L.J., and Coombes K.R. Validation of oligonucleotide microarray data using microfluidic low-density arrays: a new statistical method to normalize real-time RT-PCR data. Biotechniques 38 (2005) 785
21. Schwarz A., Gwinner W., Hiss M., Radermacher J., Mengel M., and Haller H. Safety and adequacy of renal transplant protocol biopsies. Am J Transplant 5 (2005) 1992
22. Allison P.D. Missing data (2001), Sage Publications, Thousand Oaks
23. Little R.J., and Rubin D.B. Statistical analysis with missing data (1987), Wiley, New York
24. Shin G.T., Kim S.J., Lee T.S., Oh C.K., and Kim H. Gene expression of perforin by peripheral blood lymphocytes as a marker of acute rejection. Nephron Clin Pract 100 (2005) c63
25. Vasconcellos L.M., Asher F., Schachter D., Zheng X.X., Vasconcellos L.H., Shapiro M., Harmon W.E., and Strom T.B. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 66 (1998) 562
26. Graziotto R., Del Prete D., Rigotti R., Anglani F., Baldan N., Furian L., Valente M., Antonello A., Marchini F., D'Angelo A., and Gambaro G. Perforin, granzyme B, and Fas ligand for molecular diagnosis of acute renal-allograft rejection: Analyses on serial biopsies suggest methodological issues. Transplantation 81 (2006) 1125
27. Van Kampen C.A., Versteeg-van der Voort Maarschalk M.F., Langerak-Langerak J., Van Beelen E., Roelen D.L., and Claas F.H. Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol 62 (2001) 201
28. Van Kampen C.A., Versteeg-van der Voort M.M.F., Roelen D.L., and Claas F.H. Primed CTLs specific for HLA class I may still be present in sensitized patients when anti-HLA antibodies have disappeared: relevance for donor selection. Transplantation 73 (2002) 1286
29. Vaessen L.M., Baan C.C., Ouwehand A.J., Balk A.H., Jutte N.H., Mochtar B., Claas F.H., and Weimar W. Differential avidity and cyclosporine sensitivity of committed donor-specific graft-infiltrating cytotoxic T cells and their precursors. Relevance for clinical cardiac graft rejection. Transplantation 57 (1994) 1051
30. Roelen D.L., Van Beelen E., Van Bree S.P., Van Rood J.J., Volker-Dieben H.J., and Claas F.H. The presence of activated donor HLA classI-reactive T lymphocytes is associated with rejection of corneal grafts. Transplantation 59 (1995) 1039
31. Olack B.J., Jaramillo A., Benshoff N.D., Kaleem Z., Swanson C.J., Lowell J.A., and Mohanakumar T. Rejection of porcine islet xenografts mediated by CD4+ T cells activated through the indirect antigen recognition pathway. Xenotransplantation 9 (2002) 393
32. Smith C.R., Jaramillo A., Liu W., Tu Y., Kaleem Z., Swanson C.J., and Mohanakumar T. CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts. Transplantation 71 (2001) 1640
33. Bumgardner G.L., Gao D., Li J., Baskin J.H., Heininger M., and Orosz C.G. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 mice. Transplantation 70 (2000) 1771
34. Morton A.L., Bell E.B., Bolton E.M., Marshall H.E., Roadknight C., McDonagh M., and Bradley J.A. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody. Eur J Immunol 23 (1993) 2078
35. Sacks S.H., and Zhou W. Locally produced complement and its role in renal allograft rejection. Am J Transplant 3 (2003) 927
36. Arvieux J., Yssel H., and Colomb M.G. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 65 (1988) 229
37. Wilkinson G.R. Drug metabolism and variability among patients in drug response. N Engl J Med 352 (2005) 2211